All In Biotech

Drug Trial Radar · NCT07226843

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NOVA-BCL6-1, A First-in-Human, Multicenter Phase 1a/1b Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of LY4584180 in Adult Participants With Previously Treated Hematologic Malignancies

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

460

Planned (sponsor's estimate)

Start

Apr 17, 2026

Primary completion

Sep 2028

Study completion Feb 2030

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in patients with previously treated blood cancers. For each participant, the study could last about 9 months or possibly longer including screening.

Conditions

  • Lymphoma, Non-Hodgkin's
  • Lymphoma, Diffuse Large B-Cell
  • Follicular Lymphoma

Interventions

  • LY4584180Drug

    administered orally

  • RituximabDrug

    administered through IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Dose-Limiting Toxicities (DLTs) and DLT-Equivalent ToxicitiesTime frame: Baseline up to Day 28
  2. Number of Participants with One or More Serious Adverse Events (SAEs) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline up to 3 Years
  3. To Evaluate the Preliminary Antitumor Activity of LY4584180: Objective Response Rate (ORR)Time frame: Baseline up to 3 Years

Locations

46 sites in 8 countries. Site status is shown where the registry gives one.

  • Mayo Clinic - Scottsdale

    Scottsdale, Arizona · Recruiting

  • City of Hope

    Duarte, California · Recruiting

  • University of California, Los Angeles (UCLA) - Medical Center

    Los Angeles, California · Recruiting

  • University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

    San Francisco, California · Recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • University of Miami - Sylvester Cancer Center

    Miami, Florida · Recruiting

  • Florida Cancer Specialists - Sarasota

    Sarasota, Florida · Recruiting

  • Emory University Hospital

    Atlanta, Georgia · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Mayo Clinic - Rochester

    Rochester, Minnesota · Recruiting

  • Columbia University

    New York, New York · Recruiting

  • University of Rochester

    Rochester, New York · Recruiting

  • The Ohio State University (OSU)

    Columbus, Ohio · Recruiting

  • Oregon Health & Science University (OHSU)

    Portland, Oregon · Not yet recruiting

  • Sarah Cannon Research Institute

    Nashville, Tennessee · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

  • Texas Oncology - DFW (Sammons CC)

    Dallas, Texas · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Not yet recruiting

  • University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance)

    Seattle, Washington · Recruiting

  • Froedtert Hospital and the Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • CHU de Nantes - Hotel-Dieu

    Nantes, France · Not yet recruiting

  • Institut Curie

    Paris, France · Not yet recruiting

  • CHU Bordeaux - Hopital Haut-Leveque - Centre Francois Magendie

    Pessac, France · Not yet recruiting

  • HCL Centre Hospitalier Lyon Sud

    Pierre-Bénite, France · Not yet recruiting

  • Oncopole Claudius Regaud

    Toulouse, France · Not yet recruiting

  • Charite Universitaetsmedizin Berlin

    Berlin, Germany · Not yet recruiting

  • Universitaetsklinikum Koeln (AoeR)

    Cologne, Germany · Not yet recruiting

  • Universitaetsklinikum Essen

    Essen, Germany · Not yet recruiting

  • Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet

    Frankfurt am Main, Germany · Not yet recruiting

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola

    Bologna, Italy · Not yet recruiting

  • Istituto Europeo di Oncologia

    Milan, Italy · Not yet recruiting

  • National Cancer Center Hospital East

    Chiba, Japan · Not yet recruiting

  • Okayama University Hospital

    Okayama, Japan · Recruiting

  • Cancer Institute Hospital of JFCR

    Tokyo, Japan · Recruiting

  • Pratia Onkologia Katowice

    Katowice, Poland · Not yet recruiting

  • Pratia MCM Krakow

    Krakow, Poland · Not yet recruiting

  • AIDPORT Sp. z o.o.

    Skorzewo, Poland · Not yet recruiting

  • Instytut Hematologii i Transfuzjologii w Warszawie

    Warsaw, Poland · Not yet recruiting

  • Institut Catala d'Oncologia - L'Hospitalet

    Barcelona, Spain · Not yet recruiting

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.